Transarterial Chemoembolization for Hepatocellular Carcinoma: Current Role and Techniques

Area of Science:

• Hepatobiliary Medicine
• Interventional Radiology
• Oncology

Background:

• Systemic therapies like immunotherapy and targeted therapy are evolving hepatocellular carcinoma (HCC) treatment.
• Transarterial chemoembolization (TCE) is gaining prominence as a potentially curative option for HCC.
• Mastering TCE techniques is crucial for optimizing treatment outcomes.

Purpose of the Study:

• To outline the current clinical indications for performing TCE in HCC patients.
• To describe key technical aspects and procedural strategies for effective TCE.
• To provide guidance for clinicians aiming for complete response using TCE.

Main Methods:

• Review of current literature and clinical guidelines on TCE for HCC.
• Delineation of established and emerging techniques for TCE delivery.
• Discussion of patient selection criteria and procedural nuances.

Main Results:

• TCE is indicated for unresectable HCC, serving as a bridge to resection or as definitive therapy.
• Technical success rates are high when performed by experienced interventional radiologists.
• Specific techniques aim to maximize tumor coverage and minimize non-target embolization.

Conclusions:

• TCE remains a cornerstone in the multimodal management of hepatocellular carcinoma.
• Understanding precise indications and mastering procedural techniques are essential for maximizing curative potential.
• Further research into optimizing TCE delivery and combination therapies is warranted.